Chu Sainte-Justine

Montreal, Quebec QC H3T 1C5

15 studies enrolling now · 59 studies all time

What they study most

ADA SCID, ALK Fusion-positive Solid or CNS Tumors, Achondroplasia, Adamantinous Craniopharyngioma, Adenosine Triphosphate Binding Cassette Transporter Protein Subfamily C Member 6, Adenovirus Infection, Adolescent Substance Use, Adrenal Insufficiency, Alagille Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Anemia, Apnea Neonatal

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors — Recruiting now
• Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy — Recruiting now
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) — Recruiting now
• A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
• Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates — Recruiting now
• Study of Individuals Affected With Hypoplasminogenemia — Recruiting now
• TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II — Recruiting now
• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy — Recruiting now
• Clinical Decision Support Tool in PARDS Pilot Study — Recruiting now
• MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma — Recruiting now
• Optimizing Tracheal Intubation Outcomes and Neonatal Safety — Recruiting now
• Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs — Recruiting now
• PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism — Recruiting now
• Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis — Recruiting now
• Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis — Running, not enrolling
• Clinician Practice Companion to Address Youth Substance Use — Starting soon
• Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. — Running, not enrolling
• Trial of Overminus Spectacle Therapy for Intermittent Exotropia — Completed
• Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency — Completed
• A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP — Stopped early
• A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease — Running, not enrolling
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia — Completed
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Running, not enrolling
• A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia — Completed
• OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome — Enrolling by invitation
• A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia — Running, not enrolling
• Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) — Completed
• Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome — Running, not enrolling
• A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children — Running, not enrolling
• A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. — Completed
• Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors — Running, not enrolling
• Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
• Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia. — Stopped early
• Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation — Stopped early
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
• Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study — Status unconfirmed
• Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome — Completed
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
• N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma — Completed
• Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease — Completed
• Heart And Lung Failure - Pediatric INsulin Titration Trial — Completed
• Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy — Completed
• Age of Blood in Children in Pediatric Intensive Care Units — Completed
• Tracheal Intubation Coaching in NICUs — Completed
• Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis — Completed
• A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy — Stopped early
• An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy — Stopped early
• Natural History Study of SCID Disorders — Enrolling by invitation